Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.

    Sonnenberg A, Genta RM.

    Aliment Pharmacol Ther. 2012 Feb;35(4):469-76. doi: 10.1111/j.1365-2036.2011.04969.x. Epub 2012 Jan 5.

    PMID:
    22221289
    [PubMed - indexed for MEDLINE]
    2.

    Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.

    Hassall E, Shepherd R, Koletzko S, Radke M, Henderson C, Lundborg P.

    Aliment Pharmacol Ther. 2012 Feb;35(3):368-79. doi: 10.1111/j.1365-2036.2011.04950.x. Epub 2011 Dec 18.

    PMID:
    22176465
    [PubMed - indexed for MEDLINE]
    3.

    Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.

    Gisbert JP, Calvet X.

    Aliment Pharmacol Ther. 2012 Jan;35(2):209-21. doi: 10.1111/j.1365-2036.2011.04937.x. Epub 2011 Nov 30. Review.

    PMID:
    22129228
    [PubMed - indexed for MEDLINE]
    4.

    Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.

    Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K, Willich SN.

    Aliment Pharmacol Ther. 2012 Jan;35(1):154-64. doi: 10.1111/j.1365-2036.2011.04901.x. Epub 2011 Nov 9.

    PMID:
    22070159
    [PubMed - indexed for MEDLINE]
    5.

    Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.

    Park HG, Jung MK, Jung JT, Kwon JG, Kim EY, Seo HE, Lee JH, Yang CH, Kim ES, Cho KB, Park KS, Lee SH, Kim KO, Jeon SW.

    Aliment Pharmacol Ther. 2012 Jan;35(1):56-65. doi: 10.1111/j.1365-2036.2011.04902.x. Epub 2011 Nov 8.

    PMID:
    22066530
    [PubMed - indexed for MEDLINE]
    6.

    Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.

    Schmidt M, Johansen MB, Robertson DJ, Maeng M, Kaltoft A, Jensen LO, Tilsted HH, Bøtker HE, Sørensen HT, Baron JA.

    Aliment Pharmacol Ther. 2012 Jan;35(1):165-74. doi: 10.1111/j.1365-2036.2011.04890.x. Epub 2011 Nov 4.

    PMID:
    22050009
    [PubMed - indexed for MEDLINE]
    7.

    Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.

    Gisbert JP, Calvet X.

    Aliment Pharmacol Ther. 2011 Dec;34(11-12):1255-68. doi: 10.1111/j.1365-2036.2011.04887.x. Epub 2011 Oct 21. Review.

    PMID:
    22017749
    [PubMed - indexed for MEDLINE]
    8.

    Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.

    Bavishi C, Dupont HL.

    Aliment Pharmacol Ther. 2011 Dec;34(11-12):1269-81. doi: 10.1111/j.1365-2036.2011.04874.x. Epub 2011 Oct 17. Review.

    PMID:
    21999643
    [PubMed - indexed for MEDLINE]
    9.

    Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease.

    Hershcovici T, Jha LK, Johnson T, Gerson L, Stave C, Malo J, Knox KS, Quan S, Fass R.

    Aliment Pharmacol Ther. 2011 Dec;34(11-12):1295-305. doi: 10.1111/j.1365-2036.2011.04870.x. Epub 2011 Oct 17. Review.

    PMID:
    21999527
    [PubMed - indexed for MEDLINE]
    10.

    Erosive oesophagitis with particular reference to Asians.

    Goh KL, Mahadeva S, Ho SH.

    Aliment Pharmacol Ther. 2011 Oct;34(7):821-2; author reply 823. doi: 10.1111/j.1365-2036.2011.04767.x. No abstract available.

    PMID:
    21896044
    [PubMed - indexed for MEDLINE]
    11.

    Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.

    Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, Kim DY, Min HJ, Park SH, Shin WG, Kim KH, Kim HY, Baik GH.

    Aliment Pharmacol Ther. 2011 Nov;34(9):1098-105. doi: 10.1111/j.1365-2036.2011.04843.x. Epub 2011 Sep 19.

    PMID:
    21923713
    [PubMed - indexed for MEDLINE]
    12.

    Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer.

    García-Iglesias P, Villoria A, Suarez D, Brullet E, Gallach M, Feu F, Gisbert JP, Barkun A, Calvet X.

    Aliment Pharmacol Ther. 2011 Oct;34(8):888-900. doi: 10.1111/j.1365-2036.2011.04830.x. Epub 2011 Sep 7.

    PMID:
    21899582
    [PubMed - indexed for MEDLINE]
    13.

    Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.

    van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E; STARS II Investigators.

    Aliment Pharmacol Ther. 2011 Oct;34(7):714-23. doi: 10.1111/j.1365-2036.2011.04789.x. Epub 2011 Aug 17.

    PMID:
    21848799
    [PubMed - indexed for MEDLINE]
    14.

    Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease.

    Hsu CS, Wang PC, Chen JH, Su WC, Tseng TC, Chen HD, Hsiao TH, Wang CC, Lin HH, Shyu RY, Chao YC.

    Aliment Pharmacol Ther. 2011 Oct;34(8):994-1004. doi: 10.1111/j.1365-2036.2011.04817.x. Epub 2011 Aug 17.

    PMID:
    21848629
    [PubMed - indexed for MEDLINE]
    15.

    Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

    Becher A, El-Serag H.

    Aliment Pharmacol Ther. 2011 Sep;34(6):618-27. doi: 10.1111/j.1365-2036.2011.04774.x. Epub 2011 Jul 20. Review.

    PMID:
    21770991
    [PubMed - indexed for MEDLINE]
    16.

    The effects of a weakly acidic meal on gastric buffering and postprandial gastro-oesophageal reflux.

    Ravi K, Francis DL, See JA, Geno DM, Katzka DA.

    Aliment Pharmacol Ther. 2011 Sep;34(5):568-75. doi: 10.1111/j.1365-2036.2011.04761.x. Epub 2011 Jul 5.

    PMID:
    21726258
    [PubMed - indexed for MEDLINE]
    17.

    Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.

    Luo JC, Huang KW, Leu HB, Chen LC, Hou MC, Li CP, Lu CL, Lin HC, Lee FY, Lee SD.

    Aliment Pharmacol Ther. 2011 Sep;34(5):519-25. doi: 10.1111/j.1365-2036.2011.04760.x. Epub 2011 Jul 5.

    PMID:
    21726257
    [PubMed - indexed for MEDLINE]
    18.

    Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?

    Chacko Y, Holtmann GJ.

    Aliment Pharmacol Ther. 2011 Jul;34(2):256. doi: 10.1111/j.1365-2036.2011.04704.x. No abstract available.

    PMID:
    21679208
    [PubMed - indexed for MEDLINE]
    19.

    Development of a refractory gastro-oesophageal reflux score using an administrative claims database.

    Gerson LB, Bonafede M, Princic N, Gregory C, Farr A, Balu S.

    Aliment Pharmacol Ther. 2011 Sep;34(5):555-67. doi: 10.1111/j.1365-2036.2011.04755.x. Epub 2011 Jun 30.

    PMID:
    21714794
    [PubMed - indexed for MEDLINE]
    20.

    Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review.

    Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, Uribe M.

    Aliment Pharmacol Ther. 2011 Sep;34(5):509-18. doi: 10.1111/j.1365-2036.2011.04746.x. Epub 2011 Jun 27.

    PMID:
    21707680
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk